case_images: PMC9315267_01
case_images: Schematic representation of the steps taken for biomarker selection in MIRIADE. CSF, cerebrospinal fluid.
case_images: fneur-13-890638-g0002.jpg
case_images: PMC9315267_01_fneur-13-890638-g0002.jpg
case_images: F2
case_images: Furthermore, ESRs developing novel biomarkers for the same type of dementia collaborated to share their selection criteria and compared selected biomarkers that would be pursued using alternative assay development techniques (antibody-based and mass spectrometry) (see the summary of the steps in Figure 2).